» Articles » PMID: 37326695

Loss of TRIM24 Promotes IL-10 Expression Via CBP/p300-dependent IFNβ1 Transcription During Macrophage Activation

Overview
Journal Inflamm Res
Date 2023 Jun 16
PMID 37326695
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As an anti-inflammatory cytokine, interleukin 10 (IL-10) plays a vital role in preventing inflammatory and autoimmune pathologies while also maintaining immune homeostasis. IL-10 production in macrophages is tightly regulated by multiple pathways. TRIM24, a member of the Transcriptional Intermediary Factor 1 (TIF1) family, contributes to antiviral immunity and macrophage M2 polarization. However, the role of TRIM24 in regulating IL-10 expression and its involvement in endotoxic shock remains unclear.

Methods: In vitro, bone marrow derived macrophages cultured with GM-CSF or M-CSF were stimulated with LPS (100ng/ml). Murine models of endotoxic shock were established by challenging the mice with different dose of LPS (i.p). RTPCR, RNA sequencing, ELISA and hematoxylin and eosin staining were performed to elucidate the role and mechanisms of TRIM24 in endotoxic shock.

Results: The expression of TRIM24 is downregulated in LPS-stimulated bone marrow-derived macrophages (BMDMs). Loss of TRIM24 boosted IL-10 expression during the late stage of LPS-stimulation in macrophages. RNA-seq analysis revealed the upregulation of IFNβ1, an upstream regulator of IL-10, in TRIM24 knockout macrophages. Treatment with C646, a CBP/p300 inhibitor, diminished the difference in both IFNβ1 and IL-10 expression between TRIM24 knockout and control macrophages. Loss of TRIM24 provided protection against LPS-induced endotoxic shock in mice.

Conclusion: Our results demonstrated that inhibiting TRIM24 promoted the expression of IFNβ1 and IL-10 during macrophage activation, therefore protecting mice from endotoxic shock. This study offers novel insights into the regulatory role of TRIM24 in IL-10 expression, making it a potentially attractive therapeutic target for inflammatory diseases.

Citing Articles

Molecular mechanisms of Sepsis attacking the immune system and solid organs.

Yang Z, Gao Y, Zhao L, Lv X, Du Y Front Med (Lausanne). 2024; 11:1429370.

PMID: 39267971 PMC: 11390691. DOI: 10.3389/fmed.2024.1429370.

References
1.
Wynn T, Chawla A, Pollard J . Macrophage biology in development, homeostasis and disease. Nature. 2013; 496(7446):445-55. PMC: 3725458. DOI: 10.1038/nature12034. View

2.
Martinez F, Gordon S . The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014; 6:13. PMC: 3944738. DOI: 10.12703/P6-13. View

3.
Murray P, Allen J, Biswas S, Fisher E, Gilroy D, Goerdt S . Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014; 41(1):14-20. PMC: 4123412. DOI: 10.1016/j.immuni.2014.06.008. View

4.
Rubtsov Y, Rasmussen J, Chi E, Fontenot J, Castelli L, Ye X . Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008; 28(4):546-58. DOI: 10.1016/j.immuni.2008.02.017. View

5.
Na Y, Stakenborg M, Seok S, Matteoli G . Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019; 16(9):531-543. DOI: 10.1038/s41575-019-0172-4. View